Status:
COMPLETED
Enteroadsorbent Polymethylsiloxane vs Probiotic Lactobacillus Reuteri in the Treatment of Rotaviral Gastroenteritis
Lead Sponsor:
University Hospital for Infectious Diseases, Croatia
Conditions:
Rotavirus Gastroenteritis
Eligibility:
All Genders
6-3 years
Phase:
PHASE4
Brief Summary
This study evaluates a new drug, new enteroadsorbent polymethylsiloxane (Enterosgel) in the treatment of rotavirus gastroenteritis in children. Half of the participants received a new drug, polymethyl...
Detailed Description
Polymethylsiloxane and probiotic L. reuteri both hasten symptoms of the rotavirus gastroenteritis but they do so by a different mode of action. Polymethylsiloxane is an enteroadsorbent and it possibl...
Eligibility Criteria
Inclusion
- age 6-36 months
- proven rotavirus gastroenteritis
- symptom duration less than 48 hours
- informed consent of the parents/caregivers
Exclusion
- rotavirus vaccination
- rotavirus infection in a patient's history
- severe acute or chronic illness with possible influence on rotavirus gastroenteritis outcome
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2017
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04116307
Start Date
January 1 2013
End Date
May 31 2017
Last Update
October 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic for Infectious Diseases
Zagreb, Croatia, 10000